SLITRK1 and pemphigus foliaceus: These findings establish cuproptosis as a novel mechanistic contributor to PF and highlight TTM’s dual role in restoring copper homeostasis and inhibiting fibrogenic pathways, offering a promising therapeutic strategy for fibrotic lung diseases.